Cradle

Engineer better proteins, faster.

Founded 2021

The Netherlands 136 employees Series B Total: $102.50M AI, Biotechnology +1

General Information

Company Name Cradle

Founded Year 2021

Location

The Netherlands

Founders / Decision Makers

Employees 136

Industries AI, Biotechnology, Pharmaceutical

Funding Stage Series B

Business Model SaaS, B2B, Platform

Revenue Model Subscription, Licensing, Usage Based

Offices as of Oct 2026

Amsterdam, The Netherlands Zurich, Switzerland

Social

BounceWatch is an independent company data service, not affiliated with Cradle. To contact Cradle, visit cradle.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cradle compare?

A PDF of Cradle and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cradle soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Cradle on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

The Netherlands Market

Market Signals All Companies

Industry Signals All Companies in The Netherlands

Cradle Alternatives

All Signals Trend Reports

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Nov 04, 2026

UCB will use Cradle in selected antibody discovery projects across their biotherapeutics pipeline.

Growth Metrics Nov 03, 2026

Cradle works with 10 of the top 25 pharma companies and has grown to a team of over 100 people.

Award Received Oct 19, 2026

Cradle was recognized as one of 13 AI drug discovery companies worth keeping an eye on in an article by Willow Shah-Neville, highlighting its standing in the AI drug discovery sector.

LinkedIn Growth Oct 19, 2026

LinkedIn followers decreased by 15% over 26 days (32,579 → 27,817).

Cradle a competitor of yours? Have our desk watch it

AI Insight

Bounce Watch AI

6 days ago

Cradle is demonstrating significant commercial traction and product innovation, highlighted by securing UCB as a major customer for antibody discovery and working with 10 of the top 25 pharma companies. This strong market penetration is complemented by the launch of EvoFlows, enhancing their AI-driven protein engineering capabilities, and recent industry recognition. Despite a minor dip in social media followers, the company's robust customer acquisition and product development signal a strong growth trajectory.

Signal Types

Customer Acquisition Product Launch Traction Recognition Growth

Strategic Labels

Market Penetration Product Innovation Customer Expansion

Next Move: Expansion

Impact: 9/10

Ideal For: Biotech VCs — Series C, Growth Equity Investors in AI/Biopharma

About Cradle

Cradle, founded in 2021, is gaining traction in the intersection of AI, Biotechnology, and Pharmaceutical industries. Based in The Netherlands, the company promises to "Engineer better proteins, faster." By leveraging AI technology, Cradle aims to generate protein candidates and enhance their properties, thus achieving breakthroughs with fewer experiments guided by personalized experimental data.

With a notable Series B investment of $73.00M closed on 01 November 2024, Cradle has secured financial backing from prominent investors such as Kindred Capital, Index Ventures, and IVP. These investments underline the confidence of leading venture firms in Cradle's innovative application of AI to protein engineering.

The company is poised for growth as it continues to disrupt traditional processes of protein development, positioning itself as a key player in its industry spaces.

Business keywords: biotech company, protein design, AI design recommendations, intellectual property ownership, machine learning platform, therapeutics development, bio-based products, enzymes, antibodies, pharmaceutical applications, industrial applications, protein engineering, protein activity optimization, protein stability enhancement, protein solubility improvement

Services & Products

Protein Engineering Optimization

AI-Driven Experimental Design

Custom Model Evaluation and Integration

Target Customers

Biopharmaceutical Companies Industrial Biotechnology Researchers R&D Teams in Biotech Therapeutics Developers

Funding Rounds & Investors (3)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$73.00M	3	Kindred Capital, Index Ventures +1	01 Nov 2024
Series A	$24.00M	1	Index Ventures	01 Nov 2023
Seed	€5.50M	10	Kindred Capital, Index Ventures +8	01 Nov 2022

Latest News

View All

Turn headwinds into opportunity in 2024

Techcrunch Nov 23, 2025

How EQT uses AI to see the startup world differently

Tech Nov 20, 2025

LEVEL UP 2025 celebrates bold and life-changing entrepreneurship

Tue.nl Sep 30, 2025

‘Europe is not the US’: Tech insiders call for smarter AI rules

Thenextweb Jul 02, 2025

Europe’s AI push: €150 billion pledge to supercharge European AI startups

Eu-startups Feb 10, 2025

Amsterdam deep tech startups that raised €1M & more in 2024

Siliconcanals.com Dec 23, 2024

Cradle Alternatives & Competitors

View All Alternatives

Cradle vs

Adaptyv Switzerland

The cloud lab for protein designers

Series A

40 employees

Biotechnology, Pharmaceutical

Compare Cradle vs Adaptyv

Cradle vs

AI Proteins United States

The perfect medicine is not found

Series A

39 employees

AI, Biotechnology

Compare Cradle vs AI Proteins

Cradle vs

Scala Biodesign Israel

One-shot protein design software.

Seed

28 employees

AI, Biotechnology

Compare Cradle vs Scala Biodesign

Also compare with:

Profluent View all alternatives

FAQ About Cradle

Engineer better proteins, faster.

Cradle was founded in 2021.

Cradle is headquartered in The Netherlands. As of Oct 2026, it also has offices in Amsterdam, The Netherlands and Zurich, Switzerland.

Cradle operates in AI, Biotechnology and Pharmaceutical. Its work centres on biotech company, protein design, AI design recommendations and intellectual property ownership. Its customers include Biopharmaceutical Companies, Industrial Biotechnology Researchers and R&D Teams in Biotech.

Cradle has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Licensing and Usage Based.

Cradle has approximately 136 employees.

Cradle has completed 3 funding rounds, raising a total of $102.50M. The latest funding stage is Series B.

Cradle offers: Protein Engineering Optimization, AI-Driven Experimental Design, Custom Model Evaluation and Integration.

Top alternatives and competitors to Cradle include Adaptyv, AI Proteins, Scala Biodesign, BioMap, Modalis Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cradle and Adaptyv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cradle, https://www.bouncewatch.com/company/cradle, updated 8 November 2026. When citing, please name BounceWatch and link this page.

Cradle

General Information

Discover More

What changed at Cradle recently?

AI Insight

About Cradle

Services & Products

Target Customers

Funding Rounds & Investors (3)

Latest News

Cradle Alternatives & Competitors

FAQ About Cradle